This information was published on 2024-10-03T02:17:30 for IP Right Filed Published.
| Field | Value |
| (210) | 2487563 (IR 1813601) |
| (220) |
05 Aug 2024
|
| (300) |
US, 12 Feb 2024, 98402032
|
| (500) |
The mark consists of the stylized wording "NATACYN" positioned above the wording (natamycin ophthalmic suspension) 5%.
|
| (511) (510) |
Class 5
Pharmaceutical compositions for ophthalmological use; topical antifungal compositions for ophthalmological use. |
| (540) |
|
| (550) | Figurative |
| (730) |
Harrow IP, LLC
|
Find out more about publications on the About page.